Further validation is needed, in particular given reported concerns about the validity of patient-reported ADEs (e.g. incorrect attributions of symptoms to drugs) [ 5].
However, additional validation is needed to determine the specificity of cross-species hybridisations, and the validity of results.
Still, he said, more extensive validation is needed and is under way.
However, further validation is needed to ascertain the model's performance in long-term simulations.
Therefore, further large-scale validation is needed to determine whether histopathological subtypes specifically affect the circulating miRNA profile.
These mutation dynamics could likely serve as a biomarker of therapeutic response, although clinical validation is needed.
Further verification and validation is needed to assess which values best represent real-world conditions.
However, some kind of subsequent empirical validation is needed to assess the model's ability to reproduce observed results.
Further clinical validation is needed to determine whether this translates to reduced procedure times, pathology costs, and follow-up procedures.
Prospective validation is needed.
Yet, validation is needed to ensure that the training is accurate.
